Vitamin E decreases extra-hepatic menaquinone-4 concentrations in rats fed menadione or phylloquinone

Mol Nutr Food Res. 2012 Jun;56(6):912-22. doi: 10.1002/mnfr.201100751.

Abstract

Scope: The mechanism for increased bleeding and decreased vitamin K status accompanying vitamin E supplementation is unknown. We hypothesized that elevated hepatic α-tocopherol (α-T) concentrations may stimulate vitamin K metabolism and excretion. Furthermore, α-T may interfere with the side chain removal of phylloquinone (PK) to form menadione (MN) as an intermediate for synthesis of tissue-specific menaquinone-4 (MK-4).

Methods and results: In order to investigate these hypotheses, rats were fed phylloquinone (PK) or menadione (MN) containing diets (2 μmol/kg) for 2.5 weeks. From day 10, rats were given daily subcutaneous injections of either α-T (100 mg/kg) or vehicle and were sacrificed 24 h after the seventh injection. Irrespective of diet, α-T injections decreased MK-4 concentrations in brain, lung, kidney, and heart; and PK in lung. These decreases were not accompanied by increased excretion of urinary 5C- or 7C-aglycone vitamin K metabolites, however, the urinary α-T metabolite (α-CEHC) increased ≥ 100-fold. Moreover, α-T increases were accompanied by downregulation of hepatic cytochrome P450 expression and modified expression of tissue ATP-binding cassette transporters.

Conclusion: Thus, in rats, high tissue α-T depleted tissue MK-4 without significantly increasing urinary vitamin K metabolite excretion. Changes in tissue MK-4 and PK levels may be a result of altered regulation of transporters.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • ATP-Binding Cassette Transporters / metabolism
  • Administration, Oral
  • Animals
  • Biotransformation
  • Chromans / urine
  • Cytochrome P-450 Enzyme System / metabolism
  • Dietary Supplements / adverse effects*
  • Gene Expression Regulation / drug effects
  • Injections, Subcutaneous
  • Liver / enzymology
  • Liver / metabolism
  • Male
  • Propionates / urine
  • RNA, Messenger / metabolism
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Tissue Distribution
  • Vitamin E / adverse effects*
  • Vitamin K 1 / administration & dosage
  • Vitamin K 1 / metabolism
  • Vitamin K 1 / pharmacokinetics*
  • Vitamin K 1 / urine
  • Vitamin K 2 / analogs & derivatives*
  • Vitamin K 2 / metabolism
  • Vitamin K 2 / urine
  • Vitamin K 3 / administration & dosage
  • Vitamin K 3 / metabolism
  • Vitamin K 3 / pharmacokinetics*
  • Vitamin K 3 / urine
  • alpha-Tocopherol / administration & dosage
  • alpha-Tocopherol / adverse effects
  • alpha-Tocopherol / metabolism
  • alpha-Tocopherol / urine

Substances

  • ATP-Binding Cassette Transporters
  • Chromans
  • Propionates
  • RNA, Messenger
  • carboxyethyl-hydroxychroman
  • Vitamin K 2
  • Vitamin E
  • menatetrenone
  • 2,5,7,8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman
  • Vitamin K 3
  • Vitamin K 1
  • Cytochrome P-450 Enzyme System
  • alpha-Tocopherol